Kengreal Sans GPI Safe in PCI, With Less Bleeding Only TIMI bleeds differed from Plavix-GPI combo in meta-analysis
For percutaneous coronary intervention (PCI) cangrelor (Kengreal) given without glycoprotein IIb/IIIa inhibitors (GPIs), yielded similar outcomes to clopidogrel (Plavix) given with them, but resulted in less bleeding, an exploratory pooled analysis of the three CHAMPION trials showed.